OR WAIT null SECS
August 02, 2016
CMOs are working hard to improve performance by investigating new technologies for filtration and purification.
CMOs that offer an innovative service-oriented model will dominate the industry.
August 01, 2016
Bio/pharmaceutical contract service provides continue to invest in development, facility upgrades, technological advancement, and mergers and acquisitions.
May 31, 2016
PharmTech sat down with an intellectual property lawyer to examine how companies are protected when they engage in activities where sharing of trade secrets must occur.
February 19, 2016
PharmSource report addresses how the opportunity for antibody drug conjugates measures up to the bio/pharma industry’s expectations.
November 02, 2015
Better process development is creating industry benchmarks for bioprocessing.
October 13, 2015
In the past, contract manufacturing organizations (CMOs) and contract development manufacturing organizations (CDMOs) have been focused most on achieving scale, reaching new clients in new geographic regions, and adding services that were previously unavailable, according to Gil Y. Roth, president of the Pharma and Biopharma Outsourcing Association. In a new report from CPhI, Roth explicates how consolidation has changed how CMOs position their services to clients and how CMOs add value to their businesses.
October 02, 2015
Despite emergence of biologics, small-molecule APIs benefit from industry growth.
September 14, 2015
PharmSource forecasts slow growth in a new report on the outlook for the contract manufacturing industry.
September 02, 2015
Suppliers indicate prices for single-use equipment are likely to increase.